Premium
Differential regulation of breast tumor cell proliferation by stromal fibroblasts of various breast tissue sources
Author(s) -
van Roozendaal Kees E. P.,
Klijn Jan G. M.,
van Ooijen Bart,
Claassen Cassandra,
Eggermont Alexander M. M.,
HenzenLogmans Sonja C.,
Foekens John A.
Publication year - 1996
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/(sici)1097-0215(19960103)65:1<120::aid-ijc20>3.0.co;2-j
Subject(s) - fibroblast , paracrine signalling , stromal cell , cancer research , cell growth , biology , breast cancer , fibroblast activation protein, alpha , pathology , cell , cell culture , cancer , medicine , receptor , biochemistry , genetics
A stromal fibroblast‐mediated paracrine regulation of epithelial tumor cell proliferation and differentiation plays an important role in the development and progression of breast tumors. We have studied the paracrine growth regulation of various phenotypically different breast cancer cell lines using conditioned serum‐free media (C‐SFM) from primary breast fibroblasts. Fibroblast cultures were established from malignant primary tumors and adjacent normal breast tissue, benign fibroadenomas, cosmetic reduction mammoplasties and breast skin tissues. All fibroblast‐conditioned media were shown to stimulate the proliferation of breast cancer cell lines. However, the C‐SFM‐induced MCF‐7 proliferative response was shown to be significantly higher than the proliferative response observed with any of the other cell lines tested. More importantly, the MCF‐7 proliferative response obtained with malignant tumor tissue fibroblast C‐SFM was shown to be significantly higher than the response to C‐SFM from paired (and unpaired) normal adjacent breast tissue fibroblasts. The MCF‐7 proliferative response to fibroblast C‐SFM from normal tissue (adjacent to the tumor) was further shown to be comparable to the MCF‐7 response using benign or reduction mammoplastic tissue fibroblast C‐SFM. In addition, we show that IGFs are only partly responsible for the observed proliferative effect of the C‐SFMs, while EGF, TGFα and basic‐FGF are shown not to be involved. We conclude that stromal fibroblasts can differentially regulate breast cancer cell proliferation. Both the fibroblast's tissue source as well as the target tumor cell's phenotype will determine the extent of the proliferative response. © 1996 Wiley‐Liss, Inc.